For the quarter ended December 2025, CVS Health (CVS) reported revenue of $105.69 billion, up 8.2% over the same period last year. EPS came in at $1.09, compared to $1.19 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $103.44 billion, representing a surprise of +2.18%. The company delivered an EPS surprise of +10.01%, with the consensus EPS estimate being $0.99.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how CVS Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Medical benefit ratio (MBR): 94.8% compared to the 94.7% average estimate based on six analysts.
- Medical membership - Total: 26.59 million compared to the 26.54 million average estimate based on five analysts.
- Medical membership - Insured - Medicare Supplement: $1.2 billion compared to the $1.22 billion average estimate based on four analysts.
- Medical membership - Medicaid - Total: $2.33 billion compared to the $2.38 billion average estimate based on four analysts.
- Revenue- Pharmacy & Consumer Wellness Segment: $37.66 billion versus $36.8 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +12.4% change.
- Revenue- Health Care Benefits: $36.29 billion versus $35.17 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +10.1% change.
- Net revenue- Health Services segment: $51.24 billion versus the six-analyst average estimate of $50.4 billion. The reported number represents a year-over-year change of +9%.
- Revenue- Pharmacy & Consumer Wellness Segment- Other: $629 million compared to the $632.17 million average estimate based on four analysts. The reported number represents a change of +2.3% year over year.
- Revenue- Health Care Benefits Segment- Services: $1.8 billion versus $1.77 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +8.5% change.
- Revenue- Health Care Benefits Segment- Net investment income: $475 million compared to the $418.54 million average estimate based on four analysts. The reported number represents a change of +19.7% year over year.
- Revenue- Health Care Benefits Segment- Premiums: $34.02 billion compared to the $32.92 billion average estimate based on four analysts. The reported number represents a change of +10.1% year over year.
- Revenue- Pharmacy & Consumer Wellness Segment- Front store: $5.66 billion compared to the $5.69 billion average estimate based on four analysts. The reported number represents a change of -0.3% year over year.
View all Key Company Metrics for CVS Health here>>>
Shares of CVS Health have returned -5.7% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CVS Health Corporation (CVS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
